Tradename | Company | Number | Date | Products |
---|---|---|---|---|
AGGRENOX | Boehringer Ingelheim | N-020884 DISCN | 1999-11-22 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
NORGESIC | Bausch Health Companies | N-013416 DISCN | 1982-10-27 | 1 products, RLD |
NORGESIC FORTE | Bausch Health Companies | N-013416 DISCN | 1982-10-27 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
YOSPRALA | Genus Lifesciences | N-205103 DISCN | 2016-09-14 | 2 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VAZALORE | PLx Pharma | N-203697 OTC | 2013-01-14 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
EQUAGESIC | Sun Pharmaceutical Industries | N-011702 DISCN | 1983-12-29 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SYNALGOS-DC | Sun Pharmaceutical Industries | N-011483 DISCN | 1983-09-06 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PRAVIGARD PAC (COPACKAGED) | Bristol Myers Squibb | N-021387 DISCN | 2003-06-24 | 6 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DARVON W/ ASA | Xanodyne Pharmaceuticals | N-010996 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DARVON COMPOUND | Xanodyne Pharmaceuticals | N-010996 DISCN | 1983-03-08 | 1 products |
DARVON COMPOUND-65 | Xanodyne Pharmaceuticals | N-010996 DISCN | 1983-03-08 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ROBAXISAL | A.H. Robins Company | N-012281 DISCN | 1982-01-01 | 1 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
10 person ansi | OTC monograph final | 2010-06-07 |
25 person ansi | OTC monograph final | 2010-06-07 |
50 person ansi | OTC monograph final | 2010-06-07 |
acetaminophen 250mg aspirin 250mg caffeine 65mg | C200263 | 2024-12-26 |
acetaminophen aspirin and caffeine | ANDA | 2024-03-05 |
acetaminophen aspirin caffeine | ANDA | 2024-11-18 |
acetaminophen, aspirin and caffeine | C200263 | 2025-07-03 |
acetaminophen, aspirin, and caffeine | C200263 | 2025-07-02 |
acetaminophen, aspirin, caffeine | C200263 | 2025-02-11 |
acetylsalicylic acid | Export only | 2025-01-15 |
Code | Description |
---|---|
G2128 | Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g. history of gastrointestinal bleed, intra-cranial bleed, blood disorders, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period) |
G8598 | Aspirin or another antiplatelet therapy used |
G8599 | Aspirin or another antiplatelet therapy not used, reason not given |
G9277 | Documentation that the patient is on daily aspirin or anti-platelet or has documentation of a valid contraindication or exception to aspirin/anti-platelet; contraindications/exceptions include anti-coagulant use, allergy to aspirin or anti-platelets, history of gastrointestinal bleed and bleeding disorder; additionally, the following exceptions documented by the physician as a reason for not taking daily aspirin or anti-platelet are acceptable (use of non-steroidal anti-inflammatory agents, documented risk for drug interaction, uncontrolled hypertension defined as >180 systolic or >110 diastolic or gastroesophageal reflux) |
G9278 | Documentation that the patient is not on daily aspirin or anti-platelet regimen |
G9793 | Patient is currently on a daily aspirin or other antiplatelet |
G9794 | Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g., history of gastrointestinal bleed, intra-cranial bleed, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period) |
G9795 | Patient is not currently on a daily aspirin or other antiplatelet |
M1055 | Aspirin or another antiplatelet therapy used |
M1056 | Prescribed anticoagulant medication during the performance period, history of gi bleeding, history of intracranial bleeding, bleeding disorder and specific provider documented reasons: allergy to aspirin or anti-platelets, use of non-steroidal anti-inflammatory agents, drug-drug interaction, uncontrolled hypertension > 180/110 mmhg or gastroesophageal reflux disease |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | 2 | 3 | 1 | 4 | 9 |
Acute coronary syndrome | D054058 | EFO_0005672 | — | — | 2 | 2 | 1 | 4 | 9 |
Coronary artery disease | D003324 | — | I25.1 | — | — | 1 | 3 | 4 | 8 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | 1 | 1 | 2 | 3 | 7 |
Peripheral arterial disease | D058729 | EFO_0004265 | — | — | — | 2 | 2 | 2 | 6 |
Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | 2 | 2 | 2 | 6 |
Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | 2 | 2 | 2 | 6 |
Syndrome | D013577 | — | — | — | 2 | 2 | 2 | — | 6 |
Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | — | 4 | 1 | 5 |
Common cold | D003139 | EFO_0007214 | J00 | — | — | 3 | 2 | — | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Thrombosis | D013927 | — | — | — | — | 3 | — | 4 | 7 |
Embolism | D004617 | — | — | — | — | 2 | — | 4 | 6 |
Venous thrombosis | D020246 | — | I82.40 | — | — | 1 | — | 4 | 5 |
Pulmonary embolism | D011655 | EFO_0003827 | I26 | — | — | 1 | — | 4 | 5 |
Hemorrhage | D006470 | MP_0001914 | R58 | — | 1 | 1 | — | 2 | 3 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | 1 | — | 2 | 3 |
Healthy volunteers/patients | — | — | — | 1 | — | 1 | — | 1 | 3 |
Unstable angina | D000789 | EFO_1000985 | I20.0 | — | — | 1 | — | 1 | 2 |
Venous thromboembolism | D054556 | EFO_0004286 | I74 | — | — | 1 | — | 1 | 2 |
Thromboembolism | D013923 | — | — | — | — | 1 | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colorectal neoplasms | D015179 | — | — | — | 1 | — | — | 3 | 4 |
Ischemic stroke | D000083242 | — | — | — | 1 | — | — | 1 | 2 |
Ischemia | D007511 | EFO_0000556 | — | — | 1 | — | — | 1 | 2 |
Transient ischemic attack | D002546 | EFO_0003764 | G45.9 | — | 1 | — | — | 1 | 2 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | — | 1 | — | — | — | 1 |
Cerebral infarction | D002544 | — | I63 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pain | D010146 | EFO_0003843 | R52 | 2 | — | — | — | — | 2 |
Pharmacokinetics | D010599 | — | — | 2 | — | — | — | — | 2 |
Sickle cell anemia | D000755 | EFO_0000697 | D57 | 1 | — | — | — | — | 1 |
Therapeutic equivalency | D013810 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Gastrointestinal neoplasms | D005770 | — | C26.9 | — | — | — | — | 3 | 3 |
Angina pectoris | D000787 | EFO_0003913 | I20 | — | — | — | — | 1 | 1 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | — | — | — | 1 | 1 |
Esophageal neoplasms | D004938 | — | C15 | — | — | — | — | 1 | 1 |
Secondary prevention | D055502 | — | — | — | — | — | — | 1 | 1 |
Time | D013995 | EFO_0000721 | — | — | — | — | — | 1 | 1 |
Dementia | D003704 | EFO_0003862 | F03 | — | — | — | — | 1 | 1 |
Depression | D003863 | — | F33.9 | — | — | — | — | 1 | 1 |
Pre-eclampsia | D011225 | EFO_0000668 | O14 | — | — | — | — | 1 | 1 |
Spontaneous abortion | D000022 | EFO_1001255 | O00.1 | — | — | — | — | 1 | 1 |
Drug common name | Aspirin |
INN | carisoprodol |
Description | Acetylsalicylic acid is a member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity. It has a role as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, a platelet aggregation inhibitor, an antipyretic, a cyclooxygenase 2 inhibitor, a cyclooxygenase 1 inhibitor, a prostaglandin antagonist, a teratogenic agent, an anticoagulant, a plant activator, an EC 1.1.1.188 (prostaglandin-F synthase) inhibitor, a drug allergen and a geroprotector. It is a member of benzoic acids, a member of salicylates and a member of phenyl acetates. It is functionally related to a salicylic acid. It is a conjugate acid of an acetylsalicylate. |
Classification | Small molecule |
Drug class | Nonsteroidal anti-inflammatory drug (NSAID) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC(=O)Oc1ccccc1C(=O)O |
PDB | — |
CAS-ID | 50-78-2 |
RxCUI | — |
ChEMBL ID | CHEMBL25 |
ChEBI ID | 15365 |
PubChem CID | 2244 |
DrugBank | DB00945 |
UNII ID | R16CO5Y76E (ChemIDplus, GSRS) |